Morgan Stanley 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-08 4:31 pm Sale |
2023-11-30 | 13G | Amicus Therapeutics, Inc. FOLD |
MORGAN STANLEY MS |
12,303,701 4.200% |
-5,281,315 (-30.03%) |
Filing |
| 2023-02-08 12:42 pm Purchase |
2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD |
MORGAN STANLEY MS |
17,585,016 6.300% |
4,847,359 (+38.06%) |
Filing |
| 2021-02-10 12:27 pm Sale |
2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
MORGAN STANLEY MS |
12,737,657 4.900% |
-1,925,794 (-13.13%) |
Filing |
| 2020-10-22 4:11 pm Purchase |
2020-10-15 | 13G | Amicus Therapeutics, Inc. FOLD |
MORGAN STANLEY MS |
14,663,451 5.700% |
12,982,050 (+772.10%) |
Filing |
| 2020-06-09 4:46 pm Sale |
2020-05-29 | 13G | Amicus Therapeutics, Inc. FOLD |
MORGAN STANLEY MS |
1,681,401 0.700% |
-11,231,264 (-86.98%) |
Filing |